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Summary
For a cancer cell to resist treatment with drugs that trap topoisomerases covalently on the 
DNA, the topoisomerase must be removed. In this study we provide the first evidence that the 
Schizosaccharomyces pombe Rad32Mre11 nuclease activity is involved in the removal of both 
Top2 from 5' DNA ends, as well as Top1 from 3' ends in vivo. A ctp1CtIP deletion is defective 
for Top2 removal, but over-proficient for Top1 removal, suggesting that Ctp1CtIP plays 
distinct roles in removing topoisomerases from 5' and 3' DNA ends. Analysis of separation of 
function mutants suggests that MRN dependent topoisomerase removal contributes 
significantly to resistance against topoisomerase-trapping drugs. This study has important 
implications for our understanding of the role of the MRN complex and CtIP in resistance of 
cells to a clinically important group of anti-cancer drugs.
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Introduction
Topoisomerases are able to release torsional stress in the DNA or resolve DNA catenanes 
through a DNA breakage and rejoining mechanism. During break formation the 
topoisomerase becomes covalently bound to the DNA. This attachment is normally short-
lived and reversible, with the protein being released upon re-ligation of the break (Champoux 
2001). Camptothecins (CPTs) and Etoposide derivatives are clinically important anti-cancer 
drugs which increase the half life of the Top1-DNA and Top2-DNA cleavage complexes, 
respectively (Baldwin et al. 2005; Pommier 2004). The prolonged presence of these 
complexes and their associated single (in the case of Top1) or double (in the case of Top2) 
DNA strand breaks interferes with replication and transcription and induces cell killing. 
Several pathways contribute to the resistance of cells treated with CPT/Etoposide. The first 
step involves the removal of the topoisomerase from the DNA, after which the remaining 
DNA break needs to be repaired. Tdp1 has been implicated in the removal of Top1 associated 
with stalled transcription machinery, rather than stalled replication forks (Pouliot et al. 1999). 
Deletions of tdp1 in both S. cerevisiae (Liu et al. 2002) and S. pombe (E.H., data not shown) 
confer only mild CPT sensitivity. Also, human patients carrying a tdp1 mutation do not show 
genetic instability or susceptibility to cancer and the pathology is most pronounced in non-
dividing cells (El-Khamisy et al. 2005; Takashima et al. 2002). A Tdp1-like activity specific 
for Top2 removal has not been identified. These data suggest that alternative activities are 
able to efficiently remove Top1 and/or Top2 from the DNA, maybe specifically in the 
context of stalled replication forks. These alternative pathways might involve nucleolytic 
cleavage of the DNA, releasing the topoisomerase together with a short DNA fragment 
(Connelly et al. 2004). 
In this study we provide the first evidence that the nuclease activity provided by the 
Schizosaccharomyces pombe Rad32Mre11/Rad50/Nbs1 (MRN) complex is involved in the 
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removal of Top2 as well as Top1 from the DNA in vivo. We also show that Ctp1CtIP is 
involved in removing Top2, but inhibits Top1 removal, suggesting that Ctp1CtIP plays distinct 
roles in removing topoisomerases from 5' and 3' DNA ends.
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Results
rad50S and the nuclease dead rad32mre11-D65N mutants are hypersensitive to 
topoisomerase poisons, but not to other DNA damaging agents
The topoisomerase-like protein Spo11 becomes covalently bound to the 5' end of the DNA 
during meiotic DSB formation. S. cerevisiae rad50S mutants are deficient in Spo11 removal, 
suggesting that the Mre11/Rad50/Nbs1 (MRN) complex is involved in Spo11 removal 
(Keeney 2001). We previously created an S. pombe rad50S mutant (rad50-K81I) which has 
been instrumental in the study of meiotic DSB formation in S. pombe (Young et al. 2002). 
This mutant is temperature sensitive for meiotic spore viability (Farah et al. 2005). In a 
separate study, we have confirmed this observation and found that the decreased spore 
viability reflects a temperature sensitive defect in the removal of Rec12Spo11 from DNA ends. 
We also found that rad50S is proficient for meiotic recombination downstream of Rec12Spo11 
removal (at restrictive temperature), which is defective in rad50Δ (unpublished data). 
Because of the topoisomerase-like properties of Rec12Spo11, we wished to establish if 
MRN is similarly involved in Top1 and Top2 removal in mitotic cells treated with CPT or 
TOP-53 (an Etoposide derivative; Utsugi et al. 1996), respectively. The high sensitivity of 
MRN mutants to topoisomerase inhibitors is similar to that of other recombinational repair 
mutants (Malik et al. 2004), and it remains unknown if the MRN complex is involved in 
topoisomerase removal, or if this sensitivity can be attributed solely to defects in downstream 
DNA repair pathways. We used the unique temperature sensitive separation of function 
properties of rad50S to distinguish between an involvement of the MRN complex in 
topoisomerase removal versus an involvement in (downstream) repair pathways. 
First, we tested the sensitivity of rad50Δ and rad50S to different DNA damaging 
agents (Fig. 1a). Whereas rad50Δ is sensitive to all agents tested (MMS, γ-irradiation, CPT 
and TOP-53), rad50S is only slightly sensitive to γ-irradiation or MMS. At 25 °C (permissive 
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temperature), rad50S is only slightly sensitive to TOP-53 and CPT, but is extremely sensitive 
to these drugs at 34 °C (restrictive temperature). This temperature sensitive rad50S 
phenotype mimics the meiotic Rec12Spo11 removal defect and suggests that rad50S might be 
defective in both Top2 and Top1 removal, but only slightly deficient for recombinational 
repair functions downstream of removal. 
It has previously been proposed that the Mre11 nuclease activity is responsible for 
Spo11 removal in S. cerevisiae (Moreau et al. 1999). We therefore created the putative 
nuclease dead rad32mre11-D65N mutant. This mutant is the equivalent of the well characterised 
S. cerevisiae mre11-D56N mutant, which has been shown to be deficient for nuclease activity 
and proficient for MRN complex formation (Krogh et al. 2005). Also in S. pombe, the 
rad32mre11-D65N mutant is proficient for MRN complex formation (Nick Rhind, personal 
communication) and is deficient for Rec12Spo11 removal (unpublished data). As Shown in Fig. 
1b, the sensitivity of rad32mre11-D65N to various DNA damaging agents is identical to that of 
the rad50S mutant (at 34 °C), suggesting that rad32mre11-D65N might be similarly defective 
for Top1/Top2 removal, but remains proficient for downstream recombinational repair 
functions.
The Rad32Mre11 nuclease activity is involved in Top1 and Top2 removal
Based on previously published procedures (Keeney et al. 1997; Shaw et al. 1975), we 
developed an assay (the DNA-linked protein detection or DLPD assay) to detect the presence 
of topoisomerases covalently bound to the DNA (see Experimental Procedures). We first 
assessed covalently bound Top1 levels at different time points after CPT addition, and found 
that these levels were higher in rad50Δ compared to WT, at all time points (see 
Supplementary Fig. 1). Maximum and comparable levels where found 1, 15 and 30 minutes 
after CPT addition, whereas at 45 minutes the levels start to decrease (possibly due to 
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increased cell death and/or decreased transcription or replication after prolonged CPT 
exposure). To interpret these results, it is important to realise that CPT and TOP-53 don't lock 
topoisomerases permanently onto the DNA, but only increase the half life of the 
topoisomerase-DNA covalent complex. The topoisomerase will eventually release itself by 
completion of the catalytic cycle (Champoux 2001) even in presence of these drugs. 
Estimates using topoisomerases from other organisms in vitro suggest these half lives in 
presence of drugs might be relatively short (Porter et al. 1989; Osheroff 1989). Therefore, the 
removal defect in MRN mutants as detected with the DPLD assay is probably an 
underestimate of the real contribution of the MRN complex to topoisomerase removal. 
For subsequent experiments, topoisomerase removal was assessed after 15 minutes of 
CPT/TOP-53 treatment. We consistently found that the amounts of covalently bound Top2 
and Top1 are both increased in rad50Δ compared to WT cells (Fig. 2). These results were 
highly reproducible: every single fraction in a series of three experiments using TOP-53 
treated cells and five experiments using CPT treated cells showed higher levels of covalently 
bound topoisomerases in rad50Δ compared to WT cells. We quantified the levels of DNA-
linked protein (see Experimental Procedures) and found that the total amount of covalently 
bound protein in rad50Δ cells compared to WT shows a 1.7 ± 0.3 and 1.4 ± 0.2 fold increase 
for Top2 and Top1, respectively. These increases are statistically significant (P=0.015, N=3 
for Top2; P = 0.007, N=5 for Top1; Paired Student's t-test). We also assessed the role of the 
Rad32mre11 endonuclease activity in Top1 and Top2 removal (Fig. 2). Like rad50Δ, the 
rad32mre11-D65N mutant also shows increased levels of covalently bound Top2 (2.0 ± 0.2 fold 
increase) and Top1 (1.7 ± 0.3 fold increase; Fig. 2). These increases are statistically 
significant (P=0.02, N=3 for Top2; P = 0.02, N=4 for Top1; Paired Student's t-test). These 
data suggest that the MRN Rad32Mre11 nuclease activity is involved in both Top1 and Top2 
removal.
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ctp1Δ is deficient for Top2 removal, but over-proficient for Top1 removal
Mutants of sae2 in S. cerevisiae have a rad50S-like phenotype, in meiosis as well as in 
mitotic cells (Prinz et al. 1997), and it has been shown that Sae2 is involved in Spo11 
removal in meiosis (Neale et al. 2005). Recently, a novel gene, called ctp1, was identified in 
S. pombe (Limbo et al. 2007; Akamatsu et al. 2008) which shows homology to S. cerevisiae 
sae2 and the mammalian tumour suppressor CtIP (Sartori et al. 2007). CtIP/Ctp1 has been 
shown to interact with the MRN complex (Sartori et al. 2007) and is involved in DSB end 
resection (Limbo et al. 2007; Sartori et al. 2007). We have found that Ctp1CtIP is required for 
Rec12Spo11 removal (unpublished data).
Because of these observations, we analysed ctp1Δ for its ability to remove covalently 
bound Top2 and Top1 from the DNA. As shown in Fig. 3a, the sensitivity of ctp1Δ to DNA 
damaging agents is identical to that of rad50Δ and the double mutant rad50Δ ctp1Δ, while 
ctp1Δ is epistatic to rad32mre11-D65N. After TOP-53 treatment ctp1Δ shows significantly 
increased levels of covalently bound Top2 compared to WT (Fig. 3b; 1.9 ± 0.2 fold increase 
after TOP-53 treatment; P = 0.002, N=3). Surprisingly, after CPT treatment, ctp1Δ shows a 
significant decrease in covalently bound Top1 compared to WT (2.5 ± 0.7 fold; P = 0.02, 
N=3) suggesting that the mutant is over-proficient for Top1 removal. To support this 
unexpected result using an independent assay, we studied the ability of pku80Δ (Ku80 
homologue; Miyoshi et al. 2003) to rescue the sensitivity of rad50Δ and ctp1Δ to CPT. 
Tomita et al. (2003) showed that the sensitivity of rad50Δ cells to various DNA damaging 
agents is rescued by the simultaneous deletion of pku70. As this rescue is dependent on Exo1, 
it was proposed that in the absence of Rad50 the Ku heterodimer needs to be removed from 
the DSB end to allow processing of the ends by Exo1 (Tomita et al. 2003). Whereas it has 
been shown that deletion of pku80 rescues the CPT sensitivity of ctp1Δ (Limbo et al. 2007), 
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we reasoned that pku80 deletion is unlikely to rescue rad50Δ to the same extent for CPT 
sensitivity, as the covalently bound Top1 molecules would still block DSB repair in the 
absence of Pku80. As we predicted (Fig. 3c), the deletion of pku80 strongly rescues the CPT 
sensitivity of ctp1Δ, whereas pku80Δ only very slightly rescues the CPT sensitivity of 
rad50Δ. These results support the conclusion that rad50Δ is defective, while ctp1Δ is 
proficient for Top1 removal.
The Top2 nucleolytic release product is absent in rad32mre11-D65N and ctp1Δ
Nucleolytic processing of topoisomerase covalent complexes is predicted to liberate the 
protein covalently attached to a short DNA oligonucleotide fragment. Neale et al. 
(2005) developed a procedure to detect Spo11-oligo complexes released from 5' DNA ends. 
They also reported a Top2-oligo product in S. cerevisiae, but this was not dependent on 
Etoposide and was not affected by mutations in rad50 and sae2 (Neale et al. 2005). The 
biological significance of this product remains unknown.
We adapted this procedure for S. pombe to detect a Top2 release product. As shown in 
Fig. 4a, we detected two bands. The first (lower) band is equivalent to complexes reported by 
Neale et al. (2005; see lane labelled "C" in Fig. 4a); it is drug-independent and does not 
depend on Rad32Mre11 nuclease activity or Ctp1. We also detected a novel Top2-oligo release 
product which, as predicted by our previous results, depends on TOP-53 and is undetectable 
in rad32mre11-D65N and ctp1Δ mutants. These observations strongly support our conclusion 
from the DLPD assay, that Rad32Mre11 nuclease activity and Ctp1 are involved in nucleolytic 
removal of covalently bound Top2.
TOP-53 treatment also produces a higher amount of a "smear" signal (Fig. 4), 
reflecting end-labelling of covalent complexes (rather than a specific release product) that 
consist of variable lengths of genomic DNA still attached to Top2. In line with our 
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observations in the DLPD assay, this TOP-53 dependent signal is increased in rad32mre11-
D65N and ctp1Δ compared to WT. 
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Discussion
Role of the MRN complex in topoisomerase removal
In this study, we provide the first evidence that the Rad32Mre11 nuclease activity is involved in 
Top1 and Top2 removal in vivo. It has previously been shown that the bacterial SbcCD 
complex (Mre11/Rad50 homologues) can remove 5' linked biotin/avidin from 
oligonucleotides in vitro (Connelly et al. 2003). It was also proposed that the MRN complex 
is involved in removing the adenovirus pTP protein, which is covalently bound to the 5' ends 
of the adenovirus genome (Stracker et al. 2002). Neale et al. (2005) reported spontaneous 
Top2-oligo complexes in S. cerevisiae, but these were not dependent on MRN, and the cells 
had not been treated with Etoposide. It thus remains unclear if these complexes are a product 
of topoisomerase removal. The authors speculated that they might result from Top2 binding 
adjacent to an existing nick (Neale et al. 2005). In this study we report a novel Top2-oligo 
species, its dependence on TOP-53 and the Rad32Mre11 nuclease activity suggests this is a true 
release product.
MRN null mutants are among the most CPT/TOP-53 sensitive mutants (Malik et al. 
2004). This sensitivity is likely due to a combination of defects in both topoisomerase 
removal and downstream repair. Our data suggest that rad50S and rad32mre11-D65N are 
proficient for recombinational repair downstream of topoisomerase removal and thus that the 
CPT and TOP-53 sensitivity of these mutants reflects defects in topoisomerase removal. The 
sensitivity of rad50S and rad32mre11-D65N mutants to these drugs is less than that of MRN 
null mutants, but remains very significant (see Fig. 1). This suggests that the MRN complex 
plays a major role in topoisomerase removal in addition to subsequent recombinational 
repair. 
Whereas rad32mre11-D65N mutants are highly CPT and TOP-53 sensitive, the 
topoisomerase removal defect as measured by the DLPD assay is relatively mild. This 
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apparent discrepancy might be explained by the ability of topoisomerases to complete the 
catalytic cycle even in presence of drugs. Furthermore, the high CPT/TOP-53 sensitivity of 
MRN mutants does not necessarily directly reflect the proportion of covalent topoisomerases 
removed by MRN. A single covalently linked topoisomerase in S-phase is potentially lethal. 
If the MRN complex is responsible for the removal of covalently bound topoisomerases in 
the context of a replication fork, this would thus lead to a disproportionally large reduction of 
viability in MRN mutants. 
The identical sensitivities of rad50S and rad32mre11-D65N to various drugs (at 
restrictive temperature for rad50S) suggest that the Rad32Mre11 nuclease activity might be 
inactive in the rad50S mutant and that Rad50 regulates Rad32Mre11 nuclease activity. Indeed, 
based on structural studies, it has been proposed that ATP-driven directional switching of 
Rad50 controls the Mre11 nuclease activity (Hopfner et al. 2001). Interestingly, the rad50S 
mutation is found in a probable protein interaction site, and, based on structural studies, it has 
previously been proposed that this site might interact with Sae2 (Hopfner et al. 2000). Sartori 
et al. (2007) showed that CtIP interacts directly with the MRN complex. This suggests that 
CtIP/Sae2 (see below) might control the Mre11 nuclease activity through its interaction with 
Rad50.
Distinct roles of Ctp1 in Top1 versus Top2 removal
In this study we show that ctp1Δ has a defect in the removal of Top2. Surprisingly, ctp1Δ is 
over-proficient for Top1 removal. It is worth noting that S. cerevisiae sae2Δ phenocopies 
rad50S for its sensitivity to DNA damaging agents (McKee et al. 1997) suggesting it is not 
involved in all aspects of recombinational DNA repair, whereas S. pombe ctp1Δ closely 
phenocopies rad50Δ (see also Limbo et al. 2007; Akamatsu et al. 2008). The fact that ctp1Δ 
is highly sensitive to CPT, while it is over-proficient in removing Top1, suggests that, like 
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rad50Δ, ctp1Δ is defective in the repair of DNA damage downstream of Top1 removal, 
possibly because of the role of Ctp1CtIP in 5'-3' nucleolytic resection (Limbo et al. 2007).
In the process of recombinational repair, the 5' and 3' ends of a DNA DSB suffer 
different fates: The 5' end is nucleolytically resected to expose a 3' overhang (Krogh et al. 
2004), which must be protected from resection and is used for strand invasion and copy 
synthesis. Our observation that Ctp1CtIP is needed for removal of 5' linked Top2 from DNA 
ends, but inhibits removal of 3' linked Top1, might suggest a role for Ctp1CtIP in protecting the 
3' DNA ends. 
A recent study (Lengsfeld et al. 2007) showed that purified S. cerevisiae Sae2 
possesses a nuclease activity which cleaves hairpin DNA structures in vitro, cooperatively 
with the MRN complex (called MRX in S. cerevisiae). Purified MRX promotes cleavage by 
enlarging a single strand gap in the DNA opposite the Sae2 cleavage site. Together with our 
data this might suggest that Ctp1CtIP is ultimately responsible for the removal of 5' linked 
proteins (Rec12Spo11 and Top2), but our data do not support a direct role of Ctp1CtIP in the 
removal of 3' linked Top1. Interestingly, Sae2 is able to cut at the base of 5' overhang flaps, 
whereas it cuts 3' flaps not at the base but within the 3' flap region in vitro (Lengsfeld et al. 
2007). This difference might explain the distinctive effects of a ctp1 deletion on Top1 versus 
Top2/Rec12Spo11 removal. 
Conclusions and outlook
The involvement of the Mre11 endo/exonuclease activity in the processing of clean DSB 
ends remains enigmatic: its 3'-5' exonuclease activity is inconsistent with the 5'-3' 
exonuclease activity required to create the 3' ssDNA ends that are used in the subsequent 
strand invasion reaction (Krogh et al. 2004). In this study we have demonstrated that the 
Rad32Mre11 nuclease activity is involved in the removal of Top2 from 5' DNA ends as well as 
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Top1 from 3' DNA ends. Our discovery that Ctp1CtIP is involved in the removal of covalently 
bound Top2 but inhibits Top1 removal shows that the protein plays distinct roles in removing 
topoisomerases from 5' and 3' DNA ends. Our findings have important implications for our 
understanding of resistance mechanisms provided by MRN and CtIP to a clinically important 
group of cancer therapeutic drugs. 
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Experimental procedures 
Yeast strains and techniques
For strain construction and propagation standard genetic methods and media were used (Gutz 
et al. 1974). Strains used and constructed in this study are listed in Supplementary Table 1. 
DNA-linked protein detection assay
We developed this assay (which is similar to the ICE bioassay; (Subramanian et al. 1995) 
based on previously published procedures (Keeney et al. 1997; Shaw et al. 1975). In short, 
untreated cells and cells treated for 15 minutes with 50 µM CPT or 100 µg/ml TOP-53 were 
washed and resuspended in lysis buffer (8 M Guanidine HCl; 30 mM Tris, 10 mM EDTA, 1 
% Sarcosyl, pH 7.5) and lysed using glass beads. The cell extract was incubated at 70 °C for 
15 minutes. After clarification (15' 13.000 RPM in an eppendorf centrifuge), one aliquot of 
extract was set aside for DNA quantification (see below) while the rest was loaded on a CsCl 
gradient, consisting of layers with densities of 1.82, 1.72, 1.50 and 1.45 g/ml respectively. The 
gradients where centrifuged for 24 hours at 30.000 RPM in a Sorvall AH650 rotor to separate 
the free proteins from the DNA.
To ensure equal DNA loading, the DNA concentration in the extract was measured 
and this value was used to adjust the volume of the fractions loaded on the slot blot. For this 
purpose, the aliquots of extract which were set aside for DNA quantification were treated 
overnight with RNase and the DNA concentration was determined fluorimetrically using 
PicoGreen (Molecular Probes/Invitrogen detection technologies). 
To confirm that our quantification procedure indeed leads to equivalent amounts of 
total DNA being loaded onto the slot blot, we quantified the amount of DNA in each of the 
fractions for 8 independent gradients. As can be seen in Supplementary Fig. 2, the total DNA 
amounts for each gradient (obtained by adding up the amounts of the individual fractions and 
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multiplying this value with the volume of each fraction loaded on the slot blot) were very 
similar, the standard deviation being less than 3 % of the average total DNA for these 8 
independent gradients.
To detect covalently bound protein in the DNA fractions the membrane was probed 
with a specific antibody. To detect Top1, we raised and affinity purified an antibody against 
peptide FSKREDVPIEKLFSK, (9 amino acids downstream of the active tyrosine). Top2-HA 
was detected using a monoclonal antibody (Santa Cruz sc-7392). The membrane was 
processed using standard Western blot procedures and visualised using chemiluminescence. 
Using this procedure, control cultures of a CPT treated top1::LEU2 strain, or of untagged 
strains in the case of meiotic or TOP-53 treated cells, only showed slight cross hybridisation 
with the top 2 fractions (9 and 10) from the CsCl gradient, which contain the free proteins. 
These fractions do not contain any DNA, are difficult to load on a slot blot as they tend to 
clog the membrane, and are therefore not loaded for most experiments.
Signals of the different fractions were quantified using ImageJ (http://rsb.info.nih.gov/
ij/). Using fraction 6 of rad50Δ (showing the strongest presence of covalently bound protein), 
a two-fold dilution series was made, spotted on a membrane, and processed as described 
above. Signals of this dilution series were used to create a standard curve. For the standard 
dilution series and the individual experiments, the signal strength of each band was 
determined and the background signal was subtracted. The standard curve was used to 
translate the signal strength of the individual fractions into relative protein amounts. To 
compare the different experiments with each other, the relative protein amounts for the 
individual bands were standardised against rad50Δ fraction 6. For every experiment, total 
levels of covalently bound protein were calculated for WT and rad50Δ by addition of the 
protein amounts in the single fractions.
In summary, the signal for Topoisomerase recovered in the DNA-containing fractions 
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of each gradient are added together for comparison between gradients. As the amount of 
DNA in these pooled fractions is identical between gradients (see Supplementary Fig. 2), the 
ratio of Topoisomerase in DNA containing fractions between gradients directly reflects the 
proportion of covalently attached protein.
To test the difference in levels of covalently bound topoisomerases between WT and 
mutants for statistical significance, the Paired Student's t-test was performed 
(http://www.physics.csbsju.edu/stats/t-test.html). Abbreviations used in the text: N sample 
size (number of experiments); P probability that the difference is due to chance.
Detection of Top2 release product
200 ml of culture (1x107 cells/ml) where treated for 15 minutes with 100 µg/ml TOP-53. After 
washing and re-suspension in a volume of 10% TCA equal to the volume of the pellet, the 
suspension was dropped into liquid nitrogen and subsequently lysed under liquid nitrogen in 
a 6850 Freezer Mill (SPEX CertiPrep). Subsequent steps where performed according to the 
published protocol (Neale et al. 2005).
17
Acknowledgements
We would like to thank Taiho Pharmaceuticals for the generous gift of TOP-53 and Thomas 
Caspari for the top2-HA construct. This work was funded by the MRC (AMC) and a CRUK 
grant to EH (CRUK C20600/A6620). We thank Eva Hoffmann, Alan Lehmann and Ross 
Chapman for comments on the manuscript.
18
Akamatsu, Y., Murayama, Y., Yamada, T., Nakazaki, T., Tsutsui, Y., Ohta, K., and Iwasaki, 
H. (2008). Molecular characterization of the role of the Schizosaccharomyces pombe 
nip1+/ctp1+ gene in DNA double-strand break repair in association with the Mre11-
Rad50-Nbs1 complex. Mol. Cell. Biol 28, 3639-51.
Baldwin, E. L., and Osheroff, N. (2005). Etoposide, topoisomerase II and cancer. Curr Med 
Chem Anticancer Agents 5, 363-72.
Champoux, J. J. (2001). DNA TOPOISOMERASES: Structure, Function, and Mechanism. 
Annual Review of Biochemistry 70, 369-413.
Connelly, J. C., de Leau, E. S., and Leach, D. R. F. (2003). Nucleolytic processing of a 
protein-bound DNA end by the E. coli SbcCD (MR) complex. DNA Repair (Amst.) 2, 
795-807.
Connelly, J. C., and Leach, D. R. F. (2004). Repair of DNA Covalently Linked to Protein. 
Molecular Cell 13, 307-316.
El-Khamisy, S. F., Saifi, G. M., Weinfeld, M., Johansson, F., Helleday, T., Lupski, J. R., and 
Caldecott, K. W. (2005). Defective DNA single-strand break repair in spinocerebellar 
ataxia with axonal neuropathy-1. Nature 434, 108-13.
Farah, J. A., Cromie, G., Steiner, W. W., and Smith, G. R. (2005). A novel recombination 
pathway initiated by the Mre11/Rad50/Nbs1 complex eliminates palindromes during 
meiosis in Schizosaccharomyces pombe. Genetics 169, 1261-74.
Gutz, H., Leslot, H., Leupold, U., and Loprieno, N. (1974). Schizosaccharomyces pombe. In 
Handbook of Genetics (New York: Plenum Press), pp. 395-446.
Hopfner, K. P., Karcher, A., Craig, L., Woo, T. T., Carney, J. P., and Tainer, J. A. (2001). 
Structural biochemistry and interaction architecture of the DNA double-strand break 
repair Mre11 nuclease and Rad50-ATPase. Cell 105, 473-85.
Hopfner, K. P., Karcher, A., Shin, D. S., Craig, L., Arthur, L. M., Carney, J. P., and Tainer, J. 
A. (2000). Structural biology of Rad50 ATPase: ATP-driven conformational control 
in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101, 
789-800.
Keeney, S. (2001). Mechanism and control of meiotic recombination initiation. Curr Top Dev 
Biol 52, 1-53.
Keeney, S., Giroux, C. N., and Kleckner, N. (1997). Meiosis-specific DNA double-strand 
breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell 
88, 375-84.
Krogh, B. O., Llorente, B., Lam, A., and Symington, L. S. (2005). Mutations in Mre11 
phosphoesterase motif I that impair Saccharomyces cerevisiae Mre11-Rad50-Xrs2 
complex stability in addition to nuclease activity. Genetics 171, 1561-70.
Krogh, B. O., and Symington, L. S. (2004). Recombination proteins in yeast. Annu Rev 
19
Genet 38, 233-71.
Lengsfeld, B. M., Rattray, A. J., Bhaskara, V., Ghirlando, R., and Paull, T. T. (2007). Sae2 is 
an endonuclease that processes hairpin DNA cooperatively with the 
Mre11/Rad50/Xrs2 complex. Mol Cell 28, 638-51.
Limbo, O., Chahwan, C., Yamada, Y., de Bruin, R. A. M., Wittenberg, C., and Russell, P. 
(2007). Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to 
control double-strand break repair by homologous recombination. Mol Cell 28, 
134-46.
Liu, C., Pouliot, J. J., and Nash, H. A. (2002). Repair of topoisomerase I covalent complexes 
in the absence of the tyrosyl-DNA phosphodiesterase Tdp1. Proc Natl Acad Sci U S 
A 99, 14970-5.
Malik, M., and Nitiss, J. L. (2004). DNA Repair Functions That Control Sensitivity to 
Topoisomerase-Targeting Drugs. Eukaryotic Cell 3. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=329506 [Accessed June 
16, 2008].
McKee, A. H., and Kleckner, N. (1997). A general method for identifying recessive diploid-
specific mutations in Saccharomyces cerevisiae, its application to the isolation of 
mutants blocked at intermediate stages of meiotic prophase and characterization of a 
new gene SAE2. Genetics 146, 797-816.
Miao, Z., Agama, K., Sordet, O., Povirk, L., Kohn, K. W., and Pommier, Y. (2006). 
Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent 
topoisomerase I cleavage complexes. DNA Repair (Amst) 5, 1489-94.
Miyoshi, T., Sadaie, M., Kanoh, J., and Ishikawa, F. (2003). Telomeric DNA ends are 
essential for the localization of Ku at telomeres in fission yeast. J. Biol. Chem 278, 
1924-31.
Moreau, S., Ferguson, J., and Symington, L. (1999). The nuclease activity of Mre11 is 
required for meiosis but not for mating type switching, end joining, or telomere 
maintenance. Mol Cell Biol 19, 556-66.
Neale, M. J., Pan, J., and Keeney, S. (2005). Endonucleolytic processing of covalent protein-
linked DNA double-strand breaks. Nature 436, 1053-7.
Osheroff, N. (1989). Effect of antineoplastic agents on the DNA cleavage/religation reaction 
of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. 
Biochemistry 28, 6157-60.
Pommier, Y. (2004). Camptothecins and topoisomerase I: a foot in the door. Targeting the 
genome beyond topoisomerase I with camptothecins and novel anticancer drugs: 
importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem 
Anticancer Agents 4, 429-34.
Porter, S. E., and Champoux, J. J. (1989). The basis for camptothecin enhancement of DNA 
20
breakage by eukaryotic topoisomerase I. Nucleic Acids Res 17, 8521-32.
Pouliot, J. J., Yao, K. C., Robertson, C. A., and Nash, H. A. (1999). Yeast gene for a Tyr-
DNA phosphodiesterase that repairs topoisomerase I complexes. Science 286, 552-5.
Prinz, S., Amon, A., and Klein, F. (1997). Isolation of COM1, a new gene required to 
complete meiotic double-strand break-induced recombination in Saccharomyces 
cerevisiae. Genetics 146, 781-95.
Sartori, A. A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., and 
Jackson, S. P. (2007). Human CtIP promotes DNA end resection. Nature 450, 509-14.
Shaw, J. L., Blanco, J., and Mueller, G. C. (1975). Simple procedure for isolation of DNA, 
RNA and protein fractions from cultured animal cells. Anal. Biochem 65, 125-31.
Stracker, T. H., Carson, C. T., and Weitzman, M. D. (2002). Adenovirus oncoproteins 
inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-52.
Subramanian, D., Kraut, E., Staubus, A., Young, D. C., and Muller, M. T. (1995). Analysis of 
topoisomerase I/DNA complexes in patients administered topotecan. Cancer Res 55, 
2097-103.
Takashima, H. et al. (2002). Mutation of TDP1, encoding a topoisomerase I-dependent DNA 
damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 
32, 267-72.
Tomita, K. et al. (2003). Competition between the Rad50 complex and the Ku heterodimer 
reveals a role for Exo1 in processing double-strand breaks but not telomeres. Mol. 
Cell. Biol 23, 5186-97.
Utsugi, T. et al. (1996). Antitumor activity of a novel podophyllotoxin derivative (TOP-53) 
against lung cancer and lung metastatic cancer. Cancer Res 56, 2809-14.
Young, J. A., Schreckhise, R. W., Steiner, W. W., and Smith, G. R. (2002). Meiotic 
recombination remote from prominent DNA break sites in S. pombe. Mol. Cell 9, 
253-63.
21
Figure Legends
Figure 1
Temperature sensitivity of rad50S to CPT and TOP-53 suggests that the MRN complex is 
involved in the removal of covalently bound Top1 and Top2 in mitotic cells. a) The rad50S 
mutant is only slightly sensitive to MMS and γ-irradiation, but is temperature sensitive to 
CPT (Top1 poison) and TOP-53 (Top2 poison). b) Sensitivity of a rad32mre11-D65N putative 
nuclease dead mutant to various DNA damaging agents is identical to that of rad50S at 34 ºC.
Figure 2
Representative examples showing increased levels of covalently bound Top1 and Top2 in 
rad50Δ and rad32mre11-D65N compared to WT. The arrow indicates where the top and bottom 
fractions of the CsCl gradient have been loaded. 
Figure 3
a) sensitivity of ctp1Δ against various DNA damaging agents is identical to that of rad50Δ 
and the rad50Δ ctp1Δ double mutant. ctp1Δ is epistatic to rad32mre11-D65N. b) ctp1Δ is 
defective for the removal of Top2, but over-proficient for Top1 removal in mitotic cells. c) In 
line with results from the DLPD assay, deletion of pku80 rescues the CPT sensitivity of 
ctp1Δ, but not that of rad50Δ. 
Figure 4
a) Autoradiograph showing the TOP-53 dependent Top2-oligo release product in WT cells, 
which is absent in rad32mre11-D65N and ctp1Δ. The control lane C shows the drug-
independent Toop2-oligo product in S. cerevisiae. b) Density trace of the autoradiograph 
presented in panel a. In WT, the TOP-53 dependent release product is visible as a small peak 
22
left of the spontaneous drug-independent release product.
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Levels of covalently bound Top1 in WT and rad50Δ at several time points after CPT addition. The 
arrow indicates where the top and bottom fractions of the CsCl gradient have been loaded. The 
bulk of the DNA is found in fractions 5, 6 and 7, which show the strongest Top1 signal in rad50Δ. 
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Quantification of total DNA amounts loaded onto the gradients to verify equal loading. Total 
amounts of DNA from 8 independent gradients where determined by measuring and adding up 
the amounts in the individual fractions. Although there was some slight variation of the 
distribution of the DNA over the different fractions between gradients (data not shown), the total 
amounts in each gradient were very similar, the standard deviation is less than 3% of the 
average.
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